Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: Expression in chronic sinusitis vs nasal polyposis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 1, 2004, Pages 54-60

  Watelet, J B ^a,b   Bachert, C ^a   Claeys, C ^a   Van Cauwenberge, P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Extracellular matrix; Matrix metalloproteinase; MMP 7; MMP 9; Nasal polyps; Paranasal sinus diseases; Sinusitis; TIMP 1

Indexed keywords

GELATINASE B; MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTERMETHOD COMPARISON; MALE; NOSE MUCOSA; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINUSITIS; STAINING; STATISTICAL SIGNIFICANCE;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; NASAL MUCOSA; NASAL POLYPS; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SINUSITIS; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0842265603     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1398-9995.2003.00364.x     Document Type: Article

References (23)

1. VAN CAUWENBERGE P, WATELET JB. Epidemiology of chronic rhinosinusitis. Thorax 2000;55 (Suppl 2):S20-S21.
2. BACHERT C, GEVAERT P, HOLTAPPELS G, CUVELIER C, VAN CAUWENBERGE P, Nasal polyposis: from cytokines to growth. Am J Rhinol 2000;14:279-290.
3. TERRIER G, BAUMAN RP, PIDOUK JM. Endoscopic and histopathological observations of chronic maxillary sinusitis. Rhinology 1976;14:129-132.
4. LECHAPT-ZALCMAN E, COSTE A, D'ORTHO MP, FRISDAL E, HARF A, LAFUMA C et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001;193:233-241.
5. BELLEGUIC C, CORBEL M, GERMAIN N, LENA H, BOICHOT E, DELAVAL PH et al. Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 2002;32:217-223.
6. VON BREDOW DC, CRESS AE, HOWARD EW, BOWDEN GT, NAGLE RB. Activation of gelatinase-tissue-inhibitors of metalloproteinase complexes by matrilysin. Biochem J 1998;331:965-972.
7. IMAI K, YOKOHAMA Y, NAKANISHI I, OHUCHI E, FUJII Y, NAKAI N et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymatic properties. J Biol Chem 1995;270:6691-6697.
8. BREW K, DINAKARPANDIAN D, NAGASE H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477: 267-283.
9. LIU CM, HONG CY, SHUN CT, WANG JS, HSIAO TY, WANG CC et al. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expressions and their differential regulation by proinflammatory cytokines and prostaglandin in nasal polyp fibroblasts. Ann Otol Rhinol Laryngol 2001;110:1129-1136.
10. LANZA DC, KENNEDY DW. Adult rhinosinusitis defined report of the rhinosinusitis task force committee meeting. Otolaryngology-Head Neck Surgery 1997;117:S1-S49.
11. GIACCHI RJ, LEBOWITZ RA, YEE HT, LIGHT JP, JACOBS JB. Histopathologic evaluation of the ethmoid bone in chronic sinusitis. Am J Rhinol 2001;15:193-197.
12. KRANE SM. Clinical importance of metalloproteinases and their inhibitors. Ann N Y Acad Sci 1994;732:1-10.
13. HARVEY P, CLARK IM, JAURAND MC, WARN RM, EDWARDS DR. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Br J Cancer 2000;83:1147-1153.
14. DAHLEN B, SHUTE J, HOWARTH P Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 1999;54:590-596.
15. GIBBS DF, SHANLEY TP, WARNER RL, MURPHY HS, VARANI J, JOHNSON KJ. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Am J Respir Cell Mol Biol 1999;20:1145-1154.
16. Cox G, JONES L, O'BYRNE KJ. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res 2000;6:2349-2355.
17. KELLY EA, BUSSE WW, JARJOUR NN. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000;162:1157-1161.
18. VAN TOORENENBERGEN AW, VAN WIJK G, VERMEULEN AM. Allergen-induced matrix metalloproteinase-9 in nasal lavage fluid. Allergy 1999;54:293-294.
19. CATALDO D, MUNAUT C, NOEL A, FRANKENNE F, BARTSCH P, FOIDART JM et al. MMP-2-and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000;123:259-267.
20. LECHAPT-ZALCMAN E, ESCUDIER E. Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases. Morphologie 2000;84:45-49.
21. MAUTINO G, HENRIQUET C, GOUGAT C, LECAM A, DAYER JM, BOUSQUET J et al Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest 1999;79:39-47.
22. YAO PM, MAITRE B, DELACOURT C, BUHLER JM, HARF A, LAFUMA C. Divergent regulation of 92-kDa gelatinase and TIMP-I by HBECs in response to IL-1beta and TNF-alpha. Am J Physiol Lung Cell Mol Physiol 1997;273:L866-L874.
23. LEMJABBAR H, GOSSET P, LAMBLIN C, TILLIE I, HARTMANN D, WALLAERT B et al. Contribution of 92 kDa Gelatinase/typeIV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999;159:1298-1307.